NCAPG2 and glioblastoma: Tumor purity is also thought to impinge on the efficacy of ICI treatment, and NCAPG2 displayed a significant correlation with purity, which was more prominent in GBM, SARC, SKCM, ACC, LUSC, STAD and others, with some similarity to TMB and MSI (Figure 7C).